Who
Hendrik Peter Scholl
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Belite Bio.
In numbers
- Trades disclosed
- 36
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $5.8M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 21 Apr 2026
- Last trade
- 1 Oct 2026
- Last filed
- 5 Oct 2026
Companies traded
Activity over time
1 Jun – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 5 Oct 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $33K200 at $163.63 | filing |
| 1 Oct 2026filed 5 Oct 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $3,95124 at $164.64 | filing |
| 1 Oct 2026filed 5 Oct 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $20K120 at $165.49 | filing |
| 1 Oct 2026filed 5 Oct 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $8,32250 at $166.44 | filing |
| 1 Oct 2026filed 5 Oct 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $13K78 at $167.59 | filing |
| 1 Oct 2026filed 5 Oct 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $2,01912 at $168.21 | filing |
| 1 Oct 2026filed 5 Oct 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $2,37114 at $169.36 | filing |
| 1 Oct 2026filed 5 Oct 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $3402 at $170.02 | filing |
| 18 Jun 2026filed 22 Jun 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $14K96 at $143.90 | filing |
| 18 Jun 2026filed 22 Jun 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $542K3,748 at $144.66 | filing |
| 18 Jun 2026filed 22 Jun 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $707K4,861 at $145.43 | filing |
| 18 Jun 2026filed 22 Jun 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $175K1,199 at $146.24 | filing |
| 18 Jun 2026filed 22 Jun 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $14K96 at $147.11 | filing |
| 18 Jun 2026filed 22 Jun 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $14K96 at $143.90 | filing |
| 18 Jun 2026filed 22 Jun 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $542K3,748 at $144.66 | filing |
| 18 Jun 2026filed 22 Jun 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $707K4,861 at $145.43 | filing |
| 18 Jun 2026filed 22 Jun 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $175K1,199 at $146.24 | filing |
| 18 Jun 2026filed 22 Jun 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $14K96 at $147.11 | filing |
| 16 Jun 2026filed 17 Jun 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $283K2,054 at $137.61 | filing |
| 16 Jun 2026filed 17 Jun 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $108K784 at $138.18 | filing |
News
Belite Bio (NASDAQ:BLTE) Insider Hendrik Peter Scholl Sells 500 Shares of Company Stockthemarketsdaily.com · 6 Oct 2026
1 headline in the last 90 days name Hendrik Peter Scholl; 0 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.